Osmitrol 15 is a brand name for mannitol, a diuretic medication used to reduce swelling and pressure in the brain and eyes [1]. It is administered intravenously [2].
What is Osmitrol 15 used for?
Osmitrol 15, containing mannitol, is primarily used to treat or prevent elevated intracranial pressure (ICP) caused by conditions such as head injuries, brain tumors, or cerebral edema [1][2]. It also helps reduce intraocular pressure in cases of acute glaucoma [1]. The medication works by drawing fluid from tissues into the bloodstream, which then increases urine output, helping to remove excess fluid from the body [2].
How is Osmitrol 15 administered?
Osmitrol 15 is given as an intravenous infusion [2]. The dosage and rate of administration depend on the patient's specific condition and response [1]. It is typically administered in a healthcare setting by a trained medical professional [2].
What are the potential side effects of Osmitrol 15?
Common side effects may include headache, dizziness, nausea, vomiting, and changes in fluid and electrolyte balance [1]. More serious side effects can occur, such as kidney problems, heart failure, or allergic reactions. It is important to monitor patients for these adverse effects during and after administration [2].
Are there any contraindications for using Osmitrol 15?
Osmitrol 15 should not be used in patients with severe dehydration, active intracranial bleeding, or severe kidney disease [1]. Caution is advised in patients with heart failure or compromised renal function [2].
How does mannitol work to reduce brain swelling?
Mannitol is an osmotic diuretic. When administered intravenously, it increases the osmolarity of the blood plasma. This causes water to move from the brain tissue, which has lower osmolarity, into the vascular space, thereby reducing brain swelling and intracranial pressure [2].